Stuart Haynes Email
Group Leader @ Cancer Research Horizons
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Stuart Haynes Work
- Group Leader @ (April 2023 - Present)
- Deputy Laboratory Head @ (October 2020 - Present)
- Principal Scientist @ (June 2015 - October 2020)
- Scientist I @ (May 2013 - May 2015)
- Postdoctoral Fellow @ (May 2010 - May 2012)
Stuart Haynes Education
- University of Warwick
Doctor of Philosophy (PhD) (Chemistry)
2006-2010 - University of Warwick
MChem (Chemistry)
2002-2006
Stuart Haynes Skills
- Analytical Chemistry
- Antibodies
- Biochemistry
- Bioinformatics
- Chemistry
- Drug Discovery
- HPLC
- In Vitro
- Microbiology
- Molecular Biology
- NMR
- Organic Synthesis
- Protein Assays
- Protein Chemistry
- Protein Engineering
- Protein Expression
- Protein Purification
Stuart Haynes Summary
- Stuart Haynes, is currently a Group Leader at Cancer Research Horizons. Stuart Haynes brings experience from previous roles at Cancer Research UK (CRUK), MedImmune and Harvard Medical School. Stuart Haynes holds a 2006 - 2010 Doctor of Philosophy (PhD) in Chemistry @ University of Warwick. With a robust skill set that includes Analytical Chemistry, Antibodies, Biochemistry, Bioinformatics, Chemistry and more. Stuart Haynes has 1 emails on RocketReach.
Looking for a different Stuart Haynes?
Find contact details for 700 million professionals.
Others Named Stuart Haynes
Stuart Haynes
Sales and Commercial Director
Wilmslow, GB
Stuart Haynes
Executive Director - Morgan Stanley Wealth Management
London, England, GB
Stuart Haynes
Administration and Policy Director
Jefferson City, MO, US
Stuart Haynes
Director of Communications
Liverpool, GB
Stuart Haynes
Head of Finance and Pennaeth Cyllid
Llandudno, GB
Stuart Haynes
Head of Finance and Compliance
Ilfracombe, GB
Top Cancer Research Horizons Employees
Brian Doigan
Lead Senior Solicitor
London, GB
Richard Wooster
Non Executive Director
United Kingdom
Aditi Banerjee
Translation Manager
London, GB
Tanya Moore
Investment Principal, Ventures
London, GB
Steve Wedge
Chief Scientific Officer - Cancer Research Horizons Therapeutic Innovation
Newcastle upon Tyne, GB
Fredrik Svensson
Group Leader (Computational Chemistry)
Cambridge, GB
Magdalena Florkowska
Principal Scientist
Cambridge, GB
John Lyons
Head of IT
London, GB
Matthew McCann
Therapeutic Accelerator Lead
London, GB
Vishal Pendharkar
Group Leader- Therapeutic Innovation
Cambridge, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co